Literature DB >> 31418986

Hepatocellular adenomas: Understanding the pathomolecular lexicon, MRI features, terminology, and pitfalls to inform a standardized approach.

Maria Zulfiqar1, Claude B Sirlin2, Norihide Yoneda3, Maxime Ronot4, Elizabeth M Hecht5, Victoria Chernyak6, Osamu Matsui3, Nina Bastati7, Ahmed Ba-Ssalamah7, Deyali Chatterjee8, Mustafa Bashir9, Kathryn J Fowler2.   

Abstract

Hepatocellular adenomas (HCAs) are benign hepatic tumors that can be complicated by bleeding and/or malignant transformation. The epidemiology of HCAs has changed over recent decades, primarily influenced by an increased incidence of obesity in both men and women. Currently, at least eight distinct pathomolecular subtypes of HCAs have been identified, several of which have distinguishing and pertinent imaging features on MRI. Emerging evidence suggests that hepatobiliary phase appearance may provide diagnostic and prognostic information. The purpose of this article is to review the current pathomolecular lexicon and imaging features with emphasis on hepatobiliary phase appearance. Level of Evidence: 5 Technical Efficacy: Stage 3 J. Magn. Reson. Imaging 2020;51:1630-1640.
© 2019 International Society for Magnetic Resonance in Medicine.

Entities:  

Keywords:  HCA subtypes; MRI; hepatobiliary contrast imaging; hepatocellular adenoma

Mesh:

Year:  2019        PMID: 31418986     DOI: 10.1002/jmri.26902

Source DB:  PubMed          Journal:  J Magn Reson Imaging        ISSN: 1053-1807            Impact factor:   4.813


  2 in total

Review 1.  Hepatic tumors: pitfall in diagnostic imaging.

Authors:  Giulia Grazzini; Diletta Cozzi; Federica Flammia; Roberta Grassi; Andrea Agostini; Maria Paola Belfiore; Alessandra Borgheresi; Maria Antonietta Mazzei; Chiara Floridi; Gianpaolo Carrafiello; Andrea Giovagnoni; Silvia Pradella; Vittorio Miele
Journal:  Acta Biomed       Date:  2020-07-13

2.  Long-term outcomes following resection of hepatocellular adenomas with small foci of malignant transformation or malignant adenomas.

Authors:  Sophie Chopinet; François Cauchy; Christian Hobeika; Aurélie Beaufrère; Nicolas Poté; Olivier Farges; Safi Dokmak; Mohamed Bouattour; Maxime Ronot; Valérie Vilgrain; Valérie Paradis; Olivier Soubrane
Journal:  JHEP Rep       Date:  2021-06-29
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.